vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and Drilling Tools International Corp (DTI). Click either name above to swap in a different company.

Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $38.5M, roughly 1.2× Drilling Tools International Corp). Drilling Tools International Corp runs the higher net margin — 3.2% vs -23.3%, a 26.4% gap on every dollar of revenue. On growth, Amarin Corp plc posted the faster year-over-year revenue change (7.0% vs -3.4%). Over the past eight quarters, Drilling Tools International Corp's revenue compounded faster (2.1% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Drilling Tools International Corp is a leading provider of specialized drilling tools, rental equipment, and related support services for the global oil and gas exploration and production sector. It primarily serves onshore and offshore drilling operators, oilfield service companies, and energy exploration firms across North America and key international energy markets, delivering durable, high-performance solutions that boost drilling efficiency and operational safety.

AMRN vs DTI — Head-to-Head

Bigger by revenue
AMRN
AMRN
1.2× larger
AMRN
$45.1M
$38.5M
DTI
Growing faster (revenue YoY)
AMRN
AMRN
+10.4% gap
AMRN
7.0%
-3.4%
DTI
Higher net margin
DTI
DTI
26.4% more per $
DTI
3.2%
-23.3%
AMRN
Faster 2-yr revenue CAGR
DTI
DTI
Annualised
DTI
2.1%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
DTI
DTI
Revenue
$45.1M
$38.5M
Net Profit
$-10.5M
$1.2M
Gross Margin
Operating Margin
2.9%
Net Margin
-23.3%
3.2%
Revenue YoY
7.0%
-3.4%
Net Profit YoY
33.0%
190.6%
EPS (diluted)
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
DTI
DTI
Q1 26
$45.1M
Q4 25
$49.2M
$38.5M
Q3 25
$49.7M
$38.8M
Q2 25
$72.7M
$39.4M
Q1 25
$42.0M
$42.9M
Q4 24
$62.3M
$39.8M
Q3 24
$42.3M
$40.1M
Q2 24
$67.5M
$37.5M
Net Profit
AMRN
AMRN
DTI
DTI
Q1 26
$-10.5M
Q4 25
$-1.2M
$1.2M
Q3 25
$-7.7M
$-903.0K
Q2 25
$-14.1M
$-2.4M
Q1 25
$-15.7M
$-1.7M
Q4 24
$-48.6M
$-1.3M
Q3 24
$-25.1M
$867.0K
Q2 24
$1.5M
$365.0K
Gross Margin
AMRN
AMRN
DTI
DTI
Q1 26
Q4 25
47.1%
Q3 25
44.7%
Q2 25
69.2%
Q1 25
59.8%
Q4 24
-15.4%
Q3 24
38.5%
Q2 24
63.4%
Operating Margin
AMRN
AMRN
DTI
DTI
Q1 26
Q4 25
-12.9%
2.9%
Q3 25
-22.4%
-1.2%
Q2 25
-22.0%
-4.2%
Q1 25
-39.9%
7.7%
Q4 24
-84.3%
4.5%
Q3 24
-59.5%
10.6%
Q2 24
-0.8%
6.0%
Net Margin
AMRN
AMRN
DTI
DTI
Q1 26
-23.3%
Q4 25
-2.5%
3.2%
Q3 25
-15.6%
-2.3%
Q2 25
-19.4%
-6.1%
Q1 25
-37.4%
-3.9%
Q4 24
-78.0%
-3.4%
Q3 24
-59.4%
2.2%
Q2 24
2.3%
1.0%
EPS (diluted)
AMRN
AMRN
DTI
DTI
Q1 26
Q4 25
$0.00
$0.04
Q3 25
$-0.02
$-0.03
Q2 25
$-0.03
$-0.07
Q1 25
$-0.04
$-0.05
Q4 24
$-0.12
$-0.06
Q3 24
$-0.06
$0.03
Q2 24
$0.00
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
DTI
DTI
Cash + ST InvestmentsLiquidity on hand
$307.8M
$3.6M
Total DebtLower is stronger
$45.8M
Stockholders' EquityBook value
$122.9M
Total Assets
$645.8M
$222.2M
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
DTI
DTI
Q1 26
$307.8M
Q4 25
$302.6M
$3.6M
Q3 25
$286.6M
$4.4M
Q2 25
$298.7M
$1.1M
Q1 25
$281.8M
$2.8M
Q4 24
$294.2M
$6.2M
Q3 24
$305.7M
$12.0M
Q2 24
$306.7M
$6.8M
Total Debt
AMRN
AMRN
DTI
DTI
Q1 26
Q4 25
$45.8M
Q3 25
$51.3M
Q2 25
$56.9M
Q1 25
$54.9M
Q4 24
$53.8M
Q3 24
Q2 24
Stockholders' Equity
AMRN
AMRN
DTI
DTI
Q1 26
Q4 25
$459.3M
$122.9M
Q3 25
$458.9M
$121.1M
Q2 25
$464.9M
$122.5M
Q1 25
$473.7M
$122.7M
Q4 24
$486.2M
$120.0M
Q3 24
$531.4M
$-123.2M
Q2 24
$551.9M
$92.8M
Total Assets
AMRN
AMRN
DTI
DTI
Q1 26
$645.8M
Q4 25
$670.8M
$222.2M
Q3 25
$659.8M
$227.4M
Q2 25
$670.1M
$230.3M
Q1 25
$655.7M
$233.2M
Q4 24
$685.3M
$222.4M
Q3 24
$750.6M
$218.8M
Q2 24
$799.9M
$166.9M
Debt / Equity
AMRN
AMRN
DTI
DTI
Q1 26
Q4 25
0.37×
Q3 25
0.42×
Q2 25
0.46×
Q1 25
0.45×
Q4 24
0.45×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
DTI
DTI
Operating Cash FlowLast quarter
$5.3M
Free Cash FlowOCF − Capex
$1.3M
FCF MarginFCF / Revenue
3.4%
Capex IntensityCapex / Revenue
10.4%
Cash ConversionOCF / Net Profit
4.38×
TTM Free Cash FlowTrailing 4 quarters
$-224.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
DTI
DTI
Q1 26
Q4 25
$15.3M
$5.3M
Q3 25
$-12.7M
$10.0M
Q2 25
$16.6M
$2.2M
Q1 25
$-12.5M
$2.4M
Q4 24
$-13.3M
$-3.7M
Q3 24
$-2.4M
$5.3M
Q2 24
$-2.7M
$1.1M
Free Cash Flow
AMRN
AMRN
DTI
DTI
Q1 26
Q4 25
$1.3M
Q3 25
$6.4M
Q2 25
$-5.4M
Q1 25
$-2.6M
Q4 24
$-6.9M
Q3 24
$2.0M
Q2 24
$-9.0M
FCF Margin
AMRN
AMRN
DTI
DTI
Q1 26
Q4 25
3.4%
Q3 25
16.5%
Q2 25
-13.6%
Q1 25
-6.1%
Q4 24
-17.3%
Q3 24
4.9%
Q2 24
-24.0%
Capex Intensity
AMRN
AMRN
DTI
DTI
Q1 26
Q4 25
10.4%
Q3 25
9.1%
Q2 25
19.2%
Q1 25
11.8%
Q4 24
8.1%
Q3 24
8.4%
Q2 24
26.9%
Cash Conversion
AMRN
AMRN
DTI
DTI
Q1 26
Q4 25
4.38×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
6.15×
Q2 24
-1.81×
2.96×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

DTI
DTI

Tool Rental$30.4M79%
Products$8.1M21%

Related Comparisons